Nov 29 Champions Biotechnology Inc
* Champions Oncology reports 50% revenue growth, accelerated progress on path to profitability and future role changes of the senior leadership
* Q2 revenue rose 50 percent to $4.5 million
* Sees FY 2017 revenue $16 million to $18 million Source text for Eikon: Further company coverage:
Brazil's Vale receives operating license for S11D iron ore mine
BRASILIA, Dec 9 Brazil's federal environment body Ibama said on Friday that it has approved the operating license for S11D, the giant iron ore mine being constructed by Vale SA in the Amazonian state of Para.
U.S. decision on Polish Patriot deal seen within coming months -agency
WARSAW, Dec 9 A decision by Washington on whether to grant Poland approval to buy eight Patriot missile defence systems from Raytheon Co could come within the next few months, a senior Raytheon official told a Polish news agency on Friday.